Variations in ‘ancient’ immune cells linked to patients’ survival in cancer

Researchers from the Cancer Science Institute of Singapore (CSI) at the National University of Singapore (NUS), have achieved breakthroughs in understanding relapse after chemotherapy for a type of cancer known as diffuse large B-cell lymphoma (DLBCL).

​Medical Xpress – latest medical and health news stories

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *